Exegenesis Bio Appoints Mahen Gundecha Chief Business Officer
PHILADELPHIA--(BUSINESS WIRE)-- #biotechnology--Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce the appointment of Mahen Gundecha as Chief Business Officer. Mahen will lead the company’s corporate development strategy, global business development activities and corporate communications. Mahen will also lead the formation of strategic partnerships across all areas of the company’s business, incl